Alembic Pharmaceuticals submitted audio recording of post-results conference call held on May 15, 2026 to BSE and NSE.
The conference call recording has been hosted on company website for investor access as required by regulations.
This submission follows the company's earlier intimation dated April 29, 2026 regarding quarterly results disclosure.